Tobacco-specific nitrosamines in new tobacco products

Irina Stepanov1, Joni Jensen, Dorothy Hatsukami

  • 1The Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Insights

New tobacco products contain varying levels of toxic tobacco-specific nitrosamines (TSNAs). Researchers analyzed TSNAs in novel tobacco products, finding levels from none to comparable with conventional brands.

Area of Science:

  • Analytical Chemistry
  • Toxicology
  • Public Health

Background:

  • Emerging tobacco products target health-conscious consumers.
  • Assessing toxicity requires data on harmful constituents like tobacco-specific nitrosamines (TSNAs).
  • Limited data exists on TSNA levels in novel tobacco products.

Purpose of the Study:

  • Quantify TSNA levels in new tobacco products.
  • Compare TSNA content with conventional tobacco and nicotine replacement products.

Main Methods:

  • Analysis of TSNAs in Ariva, Stonewall, Exalt, Revel, Smokey Mountain, and Quest.
  • Comparative analysis with nicotine replacement products and traditional tobacco brands.

Main Results:

  • Smokey Mountain (tobacco-free) had no detectable TSNAs.
  • Ariva and Stonewall showed the lowest TSNA levels (0.26-0.28 microg/g).
  • Exalt had the highest TSNA levels (3.3 microg/g), with Revel and Quest intermediate.

Conclusions:

  • TSNA levels in new tobacco products vary significantly.
  • Some new products contain TSNAs comparable to conventional tobacco brands.
  • Further research is needed to evaluate the health implications of these TSNA levels.

Related Concept Videos

2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...